The Chosun Ilbo on MSN
K-Bio stocks surge 80%: Will rally continue in 2025?
Seers Technology, D&D Pharmatech, OliX, ABL Bio. Among the top 10 stocks by share price growth this year, four were ...
The Chosun Ilbo on MSN
K-Bio Tech exports surge to record $14.5 billion driven by platform deals
Domestic pharmaceutical and biotech companies’ technology export volume exceeded 20 trillion Korean won this year, marking a ...
FDA has taken steps to embrace AI in 2025, announcing in December that it will be providing agency staff with agentic AI ...
The JV was formed through Corteva Catalyst, Corteva’s investment and collaboration platform. Since its launch in March of ...
China's bio-manufacturing industry flourished during the 14th Five-Year Plan period (2021-2025), achieving breakthroughs in ...
Jeff Leek (left) and Robert Bradley, co-founders of Synthesize Bio and researchers at Fred Hutchinson Cancer Center. (LinkedIn Photo) Synthesize Bio, a Seattle-based startup founded by leaders from ...
Say you want to listen in on a group of super-intelligent aliens whose language you don't understand, and whose spaceship only flies by Earth once an hour. It's not unlike what Harvard scientists and ...
Drug development is a notoriously slow, complex and costly process, with over 90% of drug candidates failing before reaching the market. A major cause of this inefficiency is the reliance on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback